Evidence map›Paper›PMID 35879277›Full record

ArticleNature communications2022

An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence.

Mario Morvan, Anna Lo Jacomo, Celia Souque, Matthew J Wade, Till Hoffmann, Koen Pouwels, Chris Lilley, Andrew C Singer, Jonathan Porter, Nicholas P Evens and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Mario Morvan *Data, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.ORCID http://orcid.org/0000-0001-8587-2112
Anna Lo Jacomo *Data, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Celia SouqueData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Matthew J WadeData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.ORCID http://orcid.org/0000-0001-9824-7121
Till HoffmannData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.ORCID http://orcid.org/0000-0003-4403-0722
Koen PouwelsNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK.ORCID http://orcid.org/0000-0001-7097-8950
Chris LilleyData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Andrew C SingerUK Centre for Ecology & Hydrology, Wallingford, OX10 8BB, UK.ORCID http://orcid.org/0000-0003-4705-6063
Jonathan PorterEnvironment Agency, National Monitoring, Starcross, Exeter, EX6 8FD, UK.ORCID http://orcid.org/0000-0003-3204-5257
Nicholas P EvensEnvironment Agency, National Monitoring, Starcross, Exeter, EX6 8FD, UK.
David I WalkerCentre for Environment, Fisheries and Aquaculture Science, Weymouth, DT4 8UB, UK.
Joshua T BunceData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Andrew EngeliData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Jasmine GrimsleyData, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Kathleen M O'Reilly *Data, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK. Kathleen.oreilly@lshtm.ac.uk.ORCID http://orcid.org/0000-0002-4892-8022
Leon Danon *Data, Analytics, and Surveillance Group, UK Health Security Agency (Formerly part of the Joint Biosecurity Centre, Department of Health and Social Care), London, SW1P 3JR, UK.
Department of Health and Social Care · GBEnvironment Agency · GBCentre for Environment, Fisheries and Aquaculture Science · GBLondon School of Hygiene & Tropical Medicine · GBPublic Health England · GBUK Centre for Ecology & Hydrology · GB

Funding

Medical Research Council MC_PC_19067Medical Research Council MC_PC_19067/2Medical Research Council MR/V038613/1
6 · The paper itself

Abstract

Accurate surveillance of the COVID-19 pandemic can be weakened by under-reporting of cases, particularly due to asymptomatic or pre-symptomatic infections, resulting in bias. Quantification of SARS-CoV-2 RNA in wastewater can be used to infer infection prevalence, but uncertainty in sensitivity and considerable variability has meant that accurate measurement remains elusive. Here, we use data from 45 sewage sites in England, covering 31% of the population, and estimate SARS-CoV-2 prevalence to within 1.1% of estimates from representative prevalence surveys (with 95% confidence). Using machine learning and phenomenological models, we show that differences between sampled sites, particularly the wastewater flow rate, influence prevalence estimation and require careful interpretation. We find that SARS-CoV-2 signals in wastewater appear 4-5 days earlier in comparison to clinical testing data but are coincident with prevalence surveys suggesting that wastewater surveillance can be a leading indicator for symptomatic viral infections. Surveillance for viruses in wastewater complements and strengthens clinical surveillance, with significant implications for public health.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsPrevalenceRNA, ViralWastewaterWastewater-Based Epidemiological MonitoringRNA, ViralWastewater

Identifiers

PMID35879277
PMCPMC9312315
OpenAlexW4287577242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.